- Trials with a EudraCT protocol (767)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
767 result(s) found for: GCP.
Displaying page 1 of 39.
EudraCT Number: 2009-011479-62 | Sponsor Protocol Number: 20090313 | Start Date*: 2009-07-24 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Visualizing VEGF producing lesions in Von Hippel-Lindau disease | ||
Medical condition: To determine if disease associated lesions in patients with VHLD can be visualized with 89Zr-bevacizumab PET scans. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-001103-35 | Sponsor Protocol Number: NSGO -EC - 0302 | Start Date*: 2004-08-20 |
Sponsor Name:Nordic Society for Gynecologic Oncology | ||
Full Title: Exemestane in Advanced or Recurrent Endometrial Carcinoma. A multicentre non-randomized Phase II study | ||
Medical condition: Advanced or recurrent endometrial carcinoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-000192-27 | Sponsor Protocol Number: GutHeart1 | Start Date*: 2015-03-19 |
Sponsor Name:Oslo University Hospital | ||
Full Title: GutHeart: Targeting Gut microbiota to treat Heart failure | ||
Medical condition: Heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001335-31 | Sponsor Protocol Number: virus-specific_CD8_T-cells_001 | Start Date*: 2013-11-08 |
Sponsor Name:Univerzita Karlova v Praze, 2. lékařská fakulta | ||
Full Title: Adoptive transfer of CMV specific CD8+ T-cells to treat CMV infection after transplantation | ||
Medical condition: chronic CMV infection after allogeneic hematopoietic stem cell transplantation in children, refractory to conventional antiviral treatment | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: CZ (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2011-005984-25 | Sponsor Protocol Number: 28-11-2011version1 | Start Date*: 2012-02-15 | |||||||||||
Sponsor Name:Bispebjerg Hospital | |||||||||||||
Full Title: Inflammation after photodynamic therapy of actinic keratoses | |||||||||||||
Medical condition: Actinic keratoses | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001976-19 | Sponsor Protocol Number: AKF-371 | Start Date*: 2006-06-12 |
Sponsor Name:Institut for Sundhedstjenesteforskning, Klinisk Farmakologi, Syddansk Universitet | ||
Full Title: “Betydningen af CYP2C19 polymorfi for escitaloprams farmakokinetik og farmakodynamik, målt som ændringer i pupildiameter” | ||
Medical condition: | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-007474-38 | Sponsor Protocol Number: GreenLight | Start Date*: 2009-03-17 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: GREEN LIGHT: Intra-operative fluorescent imaging of sentinel lymph nodes in breast cancer | ||
Medical condition: Breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001705-26 | Sponsor Protocol Number: CYD-GER-0401 | Start Date*: 2005-09-21 |
Sponsor Name:Spirig Pharma AG | ||
Full Title: Efficacy and safety of topically applied cyclodextrin gel (Spirig Pharma) in the treatment of recurrent genital herpes simplex virus infections: a randomised, double-blind, placebo-controlled, mult... | ||
Medical condition: Genito-anal herpes simplex infections | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001269-10 | Sponsor Protocol Number: Doc-Pred | Start Date*: 2016-07-14 |
Sponsor Name:Erasmus MC Cancer Institute | ||
Full Title: A pharmacokinetic study of Docetaxel and Prednisone in men with metastatic castration-resistant or hormone-sensitive prostate cancer. | ||
Medical condition: Metastatic prostate cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003522-86 | Sponsor Protocol Number: P18.210 | Start Date*: 2019-03-21 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Imaging tumor angiogenesis using 18F-Fluciclatide PET/CT in patients with colorectal and pancreatic cancer. | ||
Medical condition: Patient suffering from colorectal or pancreatic adenocarcinoma. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-006012-31 | Sponsor Protocol Number: 29-11-2011version1 | Start Date*: 2012-02-06 | |||||||||||
Sponsor Name:Bispeberg Hospital | |||||||||||||
Full Title: Reducing light sensitivity after photodynamic therapy | |||||||||||||
Medical condition: Sun damage skin | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-012433-30 | Sponsor Protocol Number: 0212009RE | Start Date*: 2009-09-23 |
Sponsor Name:Reanal Pte. Ltd. | ||
Full Title: Open, self-controlled phase IV. clinical study of the Nicoflex ointment on patients with knee arthrosis | ||
Medical condition: The aim of the study is to proove the efficacy of Nicoflex ointment on patients with knee arthrosis in a GCP trial. Patients are selected in ambulance. Patients involved the study are on standard t... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004349-34 | Sponsor Protocol Number: 202003 | Start Date*: 2020-06-17 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Early mental response to hormonal treatment in transgender men | ||
Medical condition: Transsexualism | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003581-42 | Sponsor Protocol Number: tacho-sec-2005 | Start Date*: 2006-03-22 |
Sponsor Name:Amtssygehuset i Roskilde | ||
Full Title: Randomiseret undersøgelse af sutureringsteknikkens betydning for myometriets tykkelse efter sectio bedømt ved ultralyd post partum. | ||
Medical condition: caesarian section | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002177-37 | Sponsor Protocol Number: 1321.7 | Start Date*: 2016-06-01 | ||||||||||||||||
Sponsor Name:Boehringer Ingelheim AB | ||||||||||||||||||
Full Title: Single dose, open label, uncontrolled, safety trial of intravenous administration of idarucizumab to paediatric patients enrolled from ongoing phase IIb/III clinical trials with dabigatran etexilat... | ||||||||||||||||||
Medical condition: | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: SE (Completed) LT (Completed) CZ (Completed) IT (Completed) DE (Completed) Outside EU/EEA GR (Completed) HU (Completed) BE (Completed) ES (Prematurely Ended) BG (Completed) AT (Completed) FI (Completed) FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-004310-19 | Sponsor Protocol Number: W00090GE303/EORTC-2139-MG | Start Date*: 2022-02-15 | |||||||||||
Sponsor Name:Pierre Fabre Médicament | |||||||||||||
Full Title: Adjuvant encorafenib & binimetinib vs. placebo in fully resected stage IIB/C BRAF V600E/K mutated melanoma: a randomized triple-blind phase III study in collaboration with the EORTC Melanoma Group | |||||||||||||
Medical condition: Resected BRAF V600E/K stage IIB/C melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) NO (Completed) AT (Completed) NL (Completed) PL (Completed) GR (Completed) CZ (Completed) HU (Completed) ES (Ongoing) PT (Prematurely Ended) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000623-73 | Sponsor Protocol Number: LIDO | Start Date*: 2016-09-29 |
Sponsor Name:FUNDACIÓN INVESTIGACIÓN BIOMÉDICA HOSPITAL PUERTA DE HIERRO | ||
Full Title: LIDOCAINE IN ISCHEMIA-REPERFUSION INJURY FROM MICROSURGICAL BREAST RECONSTRUCTION. RANDOMISED UNICENTRIC, DOUBLE-BLIND, CLINICAL, CONTROLLED TRIAL. | ||
Medical condition: Ischemia-reperfusion injury from breast reconstruction microsurgical flaps. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003643-10 | Sponsor Protocol Number: NAM | Start Date*: Information not available in EudraCT |
Sponsor Name:UMC Utrecht | ||
Full Title: Modulating regulatory T cell function in JIA with Vitamin B3 (nicotinamide) treatment | ||
Medical condition: Juvenile idiopathic arthritis (JIA) | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-011926-32 | Sponsor Protocol Number: ALF-BID-1108 | Start Date*: 2009-10-21 |
Sponsor Name:Exalenz Bioscience Ltd [...] | ||
Full Title: Breath Test for Patients with Acute Liver Disease for early Detection of the Need for Transplant or Recovery | ||
Medical condition: The study will look at the liver metabolic function in patients with acute liver failure. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2010-024624-20 | Sponsor Protocol Number: OCRD2010/22 | Start Date*: 2011-07-12 |
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust and University of Cambridge | ||
Full Title: A Pilot Study Investigating the Sensitivity of 18F-labelled Sodium Fluoride PET-CT for Detecting Skeletal Metastases in Renal Cell Carcinoma compared to Planar Bone Scintigraphy and Multidetector CT | ||
Medical condition: Metastatic renal cell carcinoma. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
